By Nick Tabor, New Era Senior Staff Writer
The
Massachusetts
company blamed for the meningitis outbreak had systemic problems with
sterilization in its drug lab, state inspectors found.
Two
Hopkinsville facilities, plus others throughout Kentucky and Tennessee,
have been using products from the company — though mostly not the ones that
cause meningitis. The U.S. Food and Drug Administration released an exhaustive
list this week of the company’s customers.
The
manufacturer, New England
Compounding Center,
has recalled all its products. So Jennie Stuart Medical Center has ceased using
a muscle relaxant it produced, called Robaxin, and has notified all 73 patients
who have received the drug since May.
The
FDA has not reported any illnesses associated with Robaxin. Jennie Stuart’s
letter to patients described the recall as a precautionary measure, according
to a hospital news release.
Additionally,
Western Kentucky Institute of Plastic, Reconstructive and Aesthetic Surgery
sent back all the antibiotic cream it purchased from the company.
“We’re
always very careful,” said Susan Valentini, the institute’s office manager
said.
She
added that the cream doesn’t enter a patient’s pores when a doctor uses it.
It’s simply a numbing agent, and since it gets cleaned off after surgery — and
never injected — it never posed any threat.
Altogether,
45 facilities in Kentucky
used products from NECC. This includes Western
Baptist Hospital
in Paducah, Pain Management Center of Paducah,
Owensboro Dermatology and The Medical Center at Bowling Green.
In
Tennessee, 64 facilities used NECC’s products,
including Gateway Medical Center
in Clarksville and more than a dozen in the
greater Nashville
area.
NECC
voluntarily halted operations on Oct. 3, after patients across the U.S. who had
received its epidural steroid injections started contracting meningitis. So far
328 people in 18 states have reported cases of meningitis, and 24 have died,
the Centers for Disease Control and Prevention reported on Wednesday. This
includes five cases and one death in Kentucky.
Massachusetts’
Department of Public Health has been investigating NECC throughout October.
Inspectors have found dirty lab equipment, failures to maintain important
sterilization tools, and a leaking boiler and dirty mat near the room where
sterile medications were produced, according to state records. NECC could lose
its pharmacy license.
No comments:
Post a Comment